PJP vs XPH
Invesco Pharmaceuticals ETF against State Street SPDR S&P Pharmaceuticals ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
36%
19 shared positions
Fee gap
22 bp
XPH is cheaper
1-year return gap
4.0 pts
XPH is ahead
Larger fund
PJP
$555M
Side by side
| PJP | XPH | |
|---|---|---|
| Fund | Invesco Pharmaceuticals ETF | State Street SPDR S&P Pharmaceuticals ETF |
| Issuer | Invesco | State Street SPDR |
| Category | Health Care | Health Care |
| Expense ratio | 0.57% | 0.35% |
| Assets | $555M | $462M |
| Average daily dollar volume | $5.1M | $15M |
| Listed | Jun 23, 2005 | Jun 19, 2006 |
| FrenzyCap score | 49 | 70 |
| 1-month return | −1.5% | −4.9% |
| 3-month return | +4.5% | −3.3% |
| Year to date | +17.5% | +15.4% |
| 1-year return | +29.5% | +33.5% |
| 30-day volatility | 15.8% | 21.3% |
| Worst drawdown, 1 year | −9.7% | −15.1% |
| Trailing 12-month yield | 0.92% | 0.42% |
| Holdings | 31 | 62 |
| Top 10 weight | 50.2% | 22.7% |
| Look-through P/E | 428.7 | — |
| Holdings vs fair value | +10.7% | +18.3% |
| Holdings above 200-day average | 77% | 59% |
| Net flow, latest 3 reported months | +$86M thru Jul 2026 | +$47M thru Jun 2026 |
| 30-day implied volatility | 17.9% | 28.4% |
| Holdings as of | as of Oct 8, 2026issuer data | as of Oct 8, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
66% of PJP · 36% of XPH
Sector mix of the stock holdings
| Sector | PJP | XPH | Gap |
|---|---|---|---|
| Health Care | 99.9% | 99.2% | +0.7% |
| Technology | 0.0% | 0.8% | −0.8% |
More: full overlap table · PJP holdings · XPH holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.